Spatial Genomics and Transcriptomics Market to Reach $667.51 Million by 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Spatial Genomics & Transcriptomics Market- (By Technique (Spatial Transcriptomics (Immunohistochemistry (IHC), In Situ Hybridization, Sequencing Techniques (Microdissection-based sequencing, In situ sequencing), Microscopy based RNA imaging, Other Spatial Transcriptomics Techniques), Spatial Genomics Analysis (FLUORESCENCE In Situ Hybridization, Sequencing Techniques, Other Spatial Genomics Analysis Techniques)), By Product (Instruments, Consumables, Software), By Application (Translational Research, Drug Discovery and Development), By End-User (Academic and Research Institutes, Contract Research Organization, Pharmaceutical and Biotechnology Companies)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Spatial Genomics & Transcriptomics Market is valued at US$ 238.84 Mn in 2022, and it is expected to reach US$ 667.51 Mn by 2031, with a CAGR of 12.3% during a forecast period of 2023-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2023

Transcriptomics focuses on analyzing gene expression patterns, while genomics provides a comprehensive overview of the entire set of genetic instructions encoded in DNA. The integrated study of genes and their corresponding mRNAs is referred to as genomics and transcriptomics. Emerging technologies, such as spatial genomics and transcriptomics, combine genomic analysis with tissue biology, offering a new dimension of insight by mapping the organization and expression of genes and transcripts within the spatial context of tissues and cells. These advancements present new research opportunities in areas such as developmental biology, disease studies, and drug discovery.